Smallpox vaccines for biodefense

Richard B. Kennedy, Inna Ovsyannikova, Gregory A. Poland

Research output: Contribution to journalArticle

31 Scopus citations

Abstract

Few diseases can match the enormous impact that smallpox has had on mankind. Its influence can be seen in the earliest recorded histories of ancient civilizations in Egypt and Mesopotamia. With fatality rates up to 30%, smallpox left its survivors with extensive scarring and other serious sequelae. It is estimated that smallpox killed 500 million people in the 19th and 20th centuries. Given the ongoing concerns regarding the use of variola as a biological weapon, this review will focus on the licensed vaccines as well as current research into next-generation vaccines to protect against smallpox and other poxviruses.

Original languageEnglish (US)
Pages (from-to)D73-D79
JournalVaccine
Volume27
Issue numberSUPPL. 4
DOIs
StatePublished - Nov 5 2009

Keywords

  • Biodefense
  • Smallpox vaccine
  • Vaccinia virus
  • Variola virus

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Smallpox vaccines for biodefense'. Together they form a unique fingerprint.

  • Cite this

    Kennedy, R. B., Ovsyannikova, I., & Poland, G. A. (2009). Smallpox vaccines for biodefense. Vaccine, 27(SUPPL. 4), D73-D79. https://doi.org/10.1016/j.vaccine.2009.07.103